Sign in Take the test
← Blog Science

ADHD and Dementia Risk: What the New JAMA Psychiatry Study Shows

A large JAMA Psychiatry study of more than 187,000 US adults aged 50 and over links ADHD to a higher risk of mild cognitive impairment or dementia. Yet more than 93% of people with ADHD in the study were not affected. What it found, its limits, and why it is an association, not proof of cause.

FindYourNeurotype Team 9 October 2026 7 min read

On 7 October 2026, researchers at the University of Pittsburgh published one of the largest studies so far on ADHD and memory problems in later life. In the journal JAMA Psychiatry, they report that adults with an ADHD diagnosis were more likely to be diagnosed with mild cognitive impairment or dementia as they aged. Before the headline "more than four times the risk" worries you, it is worth looking at what the study actually measured, and at a figure that got far less attention: most people with ADHD in this study did not develop any cognitive impairment.

What the Researchers Did

The team, led by co-first authors Guilherme Bauer-Negrini and Douglas Teixeira Leffa with senior author Tharick A. Pascoal, used the NIH All of Us Research Program, a large US database of volunteers who share their health records and genetic data. The study included 187,341 adults aged 50 and older (average age 56, 57% women), whose electronic health records covered about 10 years on average.

The researchers looked at ADHD in two independent ways:

  • A recorded diagnosis: 3,026 participants (1.6%) had ADHD in their medical records.
  • A genetic score: a polygenic risk score adds up thousands of small, common genetic variants linked to ADHD. Everyone has such a score, whether or not they have ever been diagnosed.

The outcome was a new diagnosis of mild cognitive impairment (MCI) or dementia. MCI means noticeable changes in memory or thinking that do not prevent a person from living independently, and it does not always progress to dementia.

What They Found

  • Raw numbers: 6.7% of people with ADHD (203 of 3,026) were diagnosed with MCI or dementia during follow-up, compared with 3.4% of people without ADHD.
  • After statistical adjustment: taking into account sex, race and ethnicity, the APOE e4 gene variant (the best-known genetic risk factor for Alzheimer's disease) and the year people joined, ADHD was linked to a risk about 4.6 times higher over time. With fuller adjustment (other health conditions, education, smoking and healthcare use), it fell to about 3 times.
  • Genes: people in the top fifth of the ADHD genetic score had a 35% higher rate of MCI or dementia than people in the bottom fifth (a hazard ratio of 1.35). The university's press release adds that this was seen even among people who had never received an ADHD diagnosis. Some outlets wrote "35% more likely to develop dementia", but in the paper the outcome is MCI and dementia combined.
  • After a diagnosis: among people who did develop cognitive impairment, those who also had ADHD more often reported poorer mental health, lower quality of life and less social satisfaction, and they used about 20% more healthcare in the following year.

Reading the Numbers Calmly

The most reassuring figure is also the simplest: more than 93% of people with ADHD in this study were not diagnosed with MCI or dementia during about ten years of records. A relative figure that sounds large ("four times") applies to a fairly small starting risk, and it describes groups, not what will happen to any one person.

A few more points matter:

  • It is an association, not proof of cause. The senior author was clear: "This doesn't prove that ADHD causes dementia" (Tharick Pascoal). ADHD often comes with other things, such as depression, sleep problems, smoking or cardiovascular issues, that also affect the brain over time.
  • The timing question is not fully settled. Early dementia can sometimes look like attention problems, so an "ADHD" diagnosis made late in life could in fact be an early sign of cognitive decline. Press coverage said the link held even when at least eight years separated the two diagnoses. That is true, but the paper shows the link was much weaker with that gap (a hazard ratio of about 1.4 instead of 4.6), and no longer statistically significant with a nine-year gap. So part of the headline figure may reflect this overlap.
  • Who was studied. All of Us participants are volunteers. In this sample, most people with ADHD were women and were more educated than is typical for adults with ADHD, and the genetic score was built mainly from data on people of European ancestry.
  • Medication remains an open question. The researchers did not have enough data on lifelong treatment to test whether ADHD medication, or any other treatment, changes the risk in either direction.

Not the First Study, but Not the Whole Picture

This result fits earlier findings from several countries. In 2021, a Swedish register study published in European Psychiatry followed about 3.6 million people born between 1932 and 1963. Adults with ADHD had higher rates of dementia, and especially of MCI. Importantly, the link shrank considerably once other psychiatric conditions (depression, anxiety, bipolar disorder and substance use) were taken into account, which suggests that these frequent companions of ADHD explain part of the story.

Other research offers a useful counterweight. A large 2026 brain-imaging study found no sign of accelerated brain aging in ADHD or autism. The two studies ask different questions, but together they suggest that ADHD does not simply mean a brain that wears out faster.

Why Might There Be a Link?

Nobody knows yet. The authors discuss possible pathways including chronic stress, sleep disturbance, physical inactivity, diet, cardiometabolic risk, injuries and substance use. Several of these overlap with the 14 potentially modifiable risk factors listed in the 2024 report of the Lancet Commission on dementia, such as physical inactivity, smoking, depression, high blood pressure and hearing loss. The Commission estimated that, across whole populations, nearly half of dementia cases might in theory be prevented or delayed if these factors were addressed. This is general public health context, not personal advice. Heart health is one thread researchers want to explore further: genetic studies have also found shared genes between ADHD and cardiovascular disease.

What This Means for You

If you have ADHD, this study is not a forecast, and no one yet knows whether the link is causal. What it does support is something useful at any age: ADHD is a lifelong condition that deserves attention in adulthood and later life, not only in childhood.

  • Look after the general basics that matter for brain health in everyone: sleep, movement, blood pressure, not smoking, social contact and hearing. None of this is specific to ADHD.
  • Mention ADHD to your doctor, especially if you notice changes in memory or concentration later in life. Knowing your history helps professionals tell long-standing ADHD apart from new changes.
  • Do not stop or change medication because of this study. It did not test treatments, so questions about medication belong with your prescriber.

If you wonder whether ADHD might be part of your own story, the free ASRS-v1.1 adult ADHD screener (18 questions, about 10 minutes) is a useful first step. A screening test is not a diagnosis, but it can help you put words on what you experience and start the conversation with a professional.

Source: Bauer-Negrini G, Leffa DT, Ferreira PCL, et al. (senior author Pascoal TA), University of Pittsburgh. Attention-Deficit/Hyperactivity Disorder and Late-Life Cognitive Impairment. JAMA Psychiatry, published online 7 October 2026, DOI 10.1001/jamapsychiatry.2026.3165. Retrospective cohort study of 187,341 adults aged 50 and older in the NIH All of Us Research Program (electronic health records and genetic data, mean follow-up about 10 years). Background: Dobrosavljevic M et al. European Psychiatry 65(1):e3 (2021), DOI 10.1192/j.eurpsy.2021.2261 (Swedish population register study, 3,591,689 people). Livingston G et al. Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission. The Lancet 404:572-628 (2024), DOI 10.1016/S0140-6736(24)01296-0.

Want to see where you stand?

Free screening tests built on published scales. Your score right away, no account needed.

Start the Neurotype test

Keep reading